Clinical Evaluation of HRV Biofeedback in Functional Neurological Disorders Compared to Placebo

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorCentre hospitalier de l'Université de Montréal (CHUM)

About this trial

Evaluation of the clinical effects of the Heart Rate Variability biofeedback training with patients suffering from Functional neurological Disorders compared with placebo.

Eligibility criteria

Qualifiers

Functional Neurological Disorders (FND) diagnosis must be medically established

Participants must have a smartphone (android ou Iphone)

Participants must be of the age of majority

Participants must have signed an informed consent

Disqualifiers

Specially protected participants: juveniles, pregnant womens, nursing mothers, law's protection peoples

Participants suffering from a severe psychiatric disease needing specialised attention

History of severe neurosurgical pathology

Alcohol dependence or drug use

Trial design

Treatments tested in this trial

  • Heart rate variability Biofeedback [HRV-BFB]
  • Pseudo HRV-BFB

Treatment groups

31 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centre hospitalier de l'Université de Montréal (CHUM)

Lead sponsor

Laboratoire de Psychologie et NeuroCognition

Collaborator